0
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The Effect of Heterologous Anti-Lymphocyte Serum on Delayed-Type Hypersensitivity in Mice

Pages 183-191 | Published online: 06 Jul 2009
 

Abstract

Rabbit anti-mouse lymphocyte serum (ALS) was capable of depressing delayed (24- and 48-hour) footpad reactions to sheep erythrocytes in mice previously sensitized with sheep erythrocytes in adjuvant. The degree of depression depended on the mode of preparation of the ALS, the dose, and the time of injection relative to the footpad test. After intraperitoneal injection of ALS there occurred: lymphopenia in blood and peritoneal fluid, the appearance of blast cells in peritoneal fluid, and a temporary loss of macrophages followed by the appearance of larger and ultrastructurally changed macrophages in the peritoneal fluid; temporary loss of macrophages also followed the injection of normal rabbit serum. The ability of different batches of ALS to depress delayed footpad reactions could not be correlated exactly with any of the other changes or with the titre of antibodies to lymph node or peritoneal lymphocytes as measured by immune adherence. Delayed footpad reactions to allogeneic lymphocytes in mice sensitized by skin allografts were depressed by ALS given just before footpad testing. In mice which had combined early (Arthus) and delayed-type hypersensitivity to sheep erythrocytes, ALS treatment also depressed the early component of the footpad reactions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.